Click here to close now.

SYS-CON MEDIA Authors: Liz McMillan, Pat Romanski, Elizabeth White, Wade Williamson, Lori MacVittie

News Feed Item

Aortic Valve Stenosis Global Clinical Trials Review, H2, 2014

LONDON, Aug. 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Aortic Valve Stenosis Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/703947/Aortic-Valve-Stenosis-Global-Clinical-Trials-Review-H2-2014.html

Aortic Valve Stenosis Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Aortic Valve Stenosis Global Clinical Trials Review, H2, 2014" provides data on the Aortic Valve Stenosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Aortic Valve Stenosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Aortic Valve Stenosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Aortic Valve Stenosis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Aortic Valve Stenosis to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Aortic Valve Stenosis to Cardiovascular Clinical Trials 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Aortic Valve Stenosis 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Aortic Valve Stenosis Therapeutics Clinical Trials 27
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Edwards Lifesciences Corporation 30
Clinical Trial Overview of Edwards Lifesciences Corporation 30
CryoLife, Inc. 31
Clinical Trial Overview of CryoLife, Inc. 31
AstraZeneca PLC 32
Clinical Trial Overview of AstraZeneca PLC 32
Pfizer Inc. 33
Clinical Trial Overview of Pfizer Inc. 33
Merck & Co., Inc. 34
Clinical Trial Overview of Merck & Co., Inc. 34
Direct Flow Medical, Inc. 35
Clinical Trial Overview of Direct Flow Medical, Inc. 35
Cerenis Therapeutics SA 36
Clinical Trial Overview of Cerenis Therapeutics SA 36
A. Menarini Industrie Farmaceutiche Riunite Srl 37
Clinical Trial Overview of A. Menarini Industrie Farmaceutiche Riunite Srl 37
Clinical Trial Overview of Top Institutes / Government 38
National Heart, Lung, and Blood Institute 38
Clinical Trial Overview of National Heart, Lung, and Blood Institute 38
Erasmus MC 39
Clinical Trial Overview of Erasmus MC 39
Assistance Publique - Hopitaux de Paris 40
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 40
Washington University School of Medicine 41
Clinical Trial Overview of Washington University School of Medicine 41
Charles University 42
Clinical Trial Overview of Charles University 42
University of Edinburgh 43
Clinical Trial Overview of University of Edinburgh 43
Asan Medical Center 44
Clinical Trial Overview of Asan Medical Center 44
Helsinki University Central Hospital 45
Clinical Trial Overview of Helsinki University Central Hospital 45
Aarhus University Hospital 46
Clinical Trial Overview of Aarhus University Hospital 46
Sahlgrenska University Hospital 47
Clinical Trial Overview of Sahlgrenska University Hospital 47
Five Key Clinical Profiles 48
Appendix 69
Abbreviations 69
Definitions 69
Research Methodology 70
Secondary Research 70
About GlobalData 71
Contact Us 71
Disclaimer 71
Source 71

List of Tables
Aortic Valve Stenosis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Aortic Valve Stenosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Aortic Valve Stenosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Aortic Valve Stenosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Aortic Valve Stenosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Aortic Valve Stenosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Aortic Valve Stenosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Aortic Valve Stenosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Aortic Valve Stenosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Aortic Valve Stenosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Aortic Valve Stenosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Aortic Valve Stenosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Aortic Valve Stenosis Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Aortic Valve Stenosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Aortic Valve Stenosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Aortic Valve Stenosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Aortic Valve Stenosis Therapeutics, Global, Suspended Clinical Trials, 2014* 23
Aortic Valve Stenosis Therapeutics, Global, Terminated Clinical Trials, 2014* 23
Aortic Valve Stenosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Aortic Valve Stenosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 25
Aortic Valve Stenosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Aortic Valve Stenosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Aortic Valve Stenosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Edwards Lifesciences Corporation, 2014* 30
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by CryoLife, Inc., 2014* 31
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 32
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 33
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 34
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Direct Flow Medical, Inc., 2014* 35
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cerenis Therapeutics SA, 2014* 36
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by A. Menarini Industrie Farmaceutiche Riunite Srl, 2014* 37
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 38
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014* 39
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 40
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014* 41
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Charles University, 2014* 42
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Edinburgh, 2014* 43
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2014* 44
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Helsinki University Central Hospital, 2014* 45
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University Hospital, 2014* 46
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sahlgrenska University Hospital, 2014* 47

List of Figures
Aortic Valve Stenosis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Aortic Valve Stenosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Aortic Valve Stenosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Aortic Valve Stenosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Aortic Valve Stenosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Aortic Valve Stenosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Proportion of Aortic Valve Stenosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Aortic Valve Stenosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Aortic Valve Stenosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Aortic Valve Stenosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Aortic Valve Stenosis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Aortic Valve Stenosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Aortic Valve Stenosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Aortic Valve Stenosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Aortic Valve Stenosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Aortic Valve Stenosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 25
Aortic Valve Stenosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Aortic Valve Stenosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Aortic Valve Stenosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 70


Read the full report:
Aortic Valve Stenosis Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/703947/Aortic-Valve-Stenosis-Global-Clinical-Trials-Review-H2-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that robomq.io will exhibit at SYS-CON's @ThingsExpo, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. robomq.io is an interoperable and composable platform that connects any device to any application. It helps systems integrators and the solution providers build new and innovative products and service for industries requiring monitoring or intelligence from devices and sensors.
The 17th International Cloud Expo has announced that its Call for Papers is open. 17th International Cloud Expo, to be held November 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA, brings together Cloud Computing, APM, APIs, Microservices, Security, Big Data, Internet of Things, DevOps and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding bu...
Today, IT is not just a cost center. IT is an enabler and driver of business. With the emergence of the hybrid cloud paradigm, IT now has increasingly more capabilities to create new strategic opportunities for a business. Hybrid cloud allows an organization to utilize multi-tenant public clouds, dedicated private clouds, bare metal hosting, and the associated support and services for the right use cases through an on-demand, XaaS model. This model of IT creates tremendous opportunities for busi...
Business as usual for IT is evolving into a “Make or Buy” decision on a service-by-service conversation with input from the LOBs. How does your organization move forward with cloud? In his general session at 16th Cloud Expo, Paul Maravei, Regional Sales Manager, Hybrid Cloud and Managed Services at Cisco, discusses how Cisco and its partners offer a market-leading portfolio and ecosystem of cloud infrastructure and application services that allow you to uniquely and securely combine cloud busi...
Businesses are looking to empower employees and departments to do more, go faster, and streamline their processes. For all workers – but mobile workers especially – utilizing the cloud to reconnect documents and improve processes without destructing existing workflows can have a dramatic impact on productivity. In his session at 16th Cloud Expo, Mark Grilli, vice president of Acrobat Solutions marketing at Adobe Systems Incorporated, will outline new ways that the cloud is changing the way peo...
SYS-CON Events announced today that Litmus Automation will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. Litmus Automation’s vision is to provide a solution for companies that are in a rush to embrace the disruptive Internet of Things technology and leverage it for real business challenges. Litmus Automation simplifies the complexity of connected devices applications with Loop, a secure and scalable clou...
While not quite mainstream yet, WebRTC is starting to gain ground with Carriers, Enterprises and Independent Software Vendors (ISV’s) alike. WebRTC makes it easy for developers to add audio and video communications into their applications by using Web browsers as their platform. But like any market, every customer engagement has unique requirements, as well as constraints. And of course, one size does not fit all. In her session at WebRTC Summit, Dr. Natasha Tamaskar, Vice President, Head of C...
With the arrival of the Big Data revolution, a data professional is expected to master a broad spectrum of complex domains including data processing, mathematics, programming languages, machine learning techniques, and business knowledge. While this mastery is undoubtedly important, this narrow focus on tool usage has divorced many from the imagination required to solve real-world problems. As the demand for analysis increases, the data science community must transform from tool experts to "data...
As Marc Andreessen says software is eating the world. Everything is rapidly moving toward being software-defined – from our phones and cars through our washing machines to the datacenter. However, there are larger challenges when implementing software defined on a larger scale - when building software defined infrastructure. In his session at 16th Cloud Expo, Boyan Ivanov, CEO of StorPool, will provide some practical insights on what, how and why when implementing "software-defined" in the dat...
SYS-CON Events announced today that WSM International (WSM), the world’s leading cloud and server migration services provider, will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. WSM is a solutions integrator with a core focus on cloud and server migration, transformation and DevOps services.
SYS-CON Events announced today that MangoApps will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY., and the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. MangoApps provides private all-in-one social intranets allowing workers to securely collaborate from anywhere in the world and from any device. Social, mobile, and eas...
SYS-CON Events announced today that Emcien will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. Emcien’s vision is to let anyone use data to know the future. Emcien has built an automated, predictive analysis product that improves the lives of real people. Emcien allows people to automate their data analysis so they can build a better future.
SYS-CON Events announced today that Solgenia will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY, and the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Solgenia is the global market leader in Cloud Collaboration and Cloud Infrastructure software solutions. Designed to “Bridge the Gap” between Personal and Professional S...
WSM International has launched a DevOps services division that offers assessment, consulting and implementation to large enterprises and organizations with complex infrastructures. The concept of DevOps is to blend information technology (IT) software development with operations to optimize the computing infrastructure according to the specific needs of the organization. According to a recent press release from Gartner, "By 2016, DevOps will evolve from a niche strategy employed by large cloud ...
SYS-CON Events announced today that QTS Realty Trust, one of the nation’s largest and fastest-growing providers of data center facilities and cloud services and a leader in security and compliance, will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. QTS Realty Trust, Inc. (NYSE: QTS) is a leading national provider of data center solutions and fully managed services, and a leader in security and compliance...